News for ARS Pharmaceuticals Inc Stock (SPRY)

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

Accesswire • 10/05/24

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Securities Law Violations

Accesswire • 10/04/24

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Assist The Schall Law Firm

Accesswire • 10/03/24

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Accesswire • 10/01/24

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Contact The Schall Law Firm

Accesswire • 09/29/24

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Accesswire • 09/28/24

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Assist The Schall Law Firm

Accesswire • 09/27/24

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Accesswire • 09/24/24

ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Should Contact The Schall Law Firm

Accesswire • 09/23/24

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc's Securities Law Violations

Accesswire • 09/22/24

The Schall Law Firm Urges Stockholders To Join An Inquiry Into ARS Pharmaceuticals Inc For Violating Securities Laws

Accesswire • 09/20/24

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And Investors With Losses Should Contact The Schall Law Firm

Accesswire • 09/19/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Law Violations And Affected Shareholders Are Urged To Reach Out

Accesswire • 09/18/24

ARS Pharmaceuticals, Inc. May Have Committed Securities Fraud And The Schall Law Firm Wants Investors To Help With An Inquiry

Accesswire • 09/17/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc For Securities Related Infractions And Shareholders Are Invited To Lend A Hand

Accesswire • 09/16/24

ARS Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Investors To Join An Inquiry

Accesswire • 09/15/24

The Schall Law Firm Is Looking Into ARS Pharmaceuticals Inc's Possible Securities Fraud And Stockholders Are Invited To Play A Part

Accesswire • 09/14/24

ARS Pharmaceuticals, Inc. May Have Committed Securities Law Violations And Investors Should Help The Schall Law Firm Investigate

Accesswire • 09/13/24

The Schall Law Firm Has Launched An Inquiry In ARS Pharmaceuticals Inc's Possible Securities Fraud And Stakeholders Are Urged To Reach Out

Accesswire • 09/12/24

ARS Pharmaceuticals, Inc. Is Being Looked Into For Securities Law Violations And The Schall Law Firm Invites Investors To Take Part

Accesswire • 09/11/24

ARS Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference

GlobeNewsWire • 09/10/24

Shareholders Can Join The Schall Law Firm In An Investigation Into ARS Pharmaceuticals Inc's Possible Fraud

Accesswire • 09/10/24

ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

GlobeNewsWire • 09/09/24

ARS Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Urges Investors To Reach Out

Accesswire • 09/09/24

The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc's Possible Securities Fraud And Shareholders Are Invited To Contribute

Accesswire • 09/07/24